Corteva, Inc. (NYSE:CTVA – Get Free Report) shares gapped up prior to trading on Tuesday after KeyCorp upgraded the stock from a sector weight rating to an overweight rating. The stock had previously closed at $12.39, but opened at $13.08. KeyCorp now has a $17.00 price target on the stock. Corteva shares last traded at $13.5960, with a volume of 7,991,892 shares traded.
A number of other analysts have also weighed in on the stock. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a $101.00 price objective on shares of Corteva in a research note on Monday, August 3rd. New Street Research set a $17.00 price target on shares of Corteva in a report on Monday. Barclays raised their price target on shares of Corteva from $84.00 to $91.00 and gave the company an “overweight” rating in a research report on Thursday, June 11th. Morgan Stanley restated an “overweight” rating and issued a $18.00 price objective on shares of Corteva in a report on Friday, October 2nd. Finally, BMO Capital Markets set a $15.00 price objective on Corteva in a research report on Friday, October 2nd. Sixteen analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $67.45.
Read Our Latest Stock Report on CTVA
Trending Headlines about Corteva
- Positive Sentiment: JPMorgan upgraded Corteva to Overweight from Neutral and set a $19 price target, implying substantial upside from recent trading levels. The firm views the post-spinoff company as undervalued. JPMorgan Upgrades Corteva to Overweight
- Positive Sentiment: KeyBanc also upgraded Corteva to Overweight following the Vylor spinoff. The second bullish rating reinforces the view that the streamlined Corteva may have better growth and valuation prospects. Corteva upgraded at KeyBanc after spinoff of Vylor
- Positive Sentiment: Options activity has surged. Investors purchased 5,408 call options, compared with typical daily volume of 856. While options flow is not a guarantee of future performance, the increase suggests stronger speculative and institutional interest in further gains.
- Positive Sentiment: Recent coverage has highlighted Corteva’s rally after the spinoff and analyst endorsements, including reports that JPMorgan sees as much as 50% upside at current valuations. Corteva Soars on JPMorgan Upgrade
- Neutral Sentiment: Corteva announced that it will release third-quarter 2026 results after the market close on November 11, followed by a webcast on November 12. The announcement provides a future catalyst but contains no new operating results. Corteva Announces Third-Quarter Earnings Date
- Negative Sentiment: One valuation analysis warned that Corteva could be overvalued after its recent advance. That concern may limit additional upside if future earnings do not support the higher valuation. Corteva Valuation Analysis
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. BlackRock Inc. bought a new stake in Corteva in the 2nd quarter worth approximately $4,560,180,000. Independent Franchise Partners LLP boosted its stake in shares of Corteva by 1.0% in the 4th quarter. Independent Franchise Partners LLP now owns 10,495,388 shares of the company’s stock worth $703,506,000 after buying an additional 107,434 shares during the last quarter. Wellington Management Group LLP boosted its stake in shares of Corteva by 941.7% in the 2nd quarter. Wellington Management Group LLP now owns 7,612,704 shares of the company’s stock worth $644,720,000 after buying an additional 6,881,875 shares during the last quarter. Royal Bank of Canada grew its holdings in shares of Corteva by 202.1% in the first quarter. Royal Bank of Canada now owns 7,458,624 shares of the company’s stock worth $624,362,000 after acquiring an additional 4,989,371 shares during the period. Finally, Jupiter Topco LLC purchased a new stake in Corteva during the second quarter valued at $544,246,000. Institutional investors own 81.54% of the company’s stock.
Corteva Stock Performance
The company has a market cap of $9.72 billion, a P/E ratio of 9.64, a P/E/G ratio of 0.73 and a beta of 0.57. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.07. The business has a fifty day simple moving average of $74.30 and a two-hundred day simple moving average of $79.19.
Corteva (NYSE:CTVA – Get Free Report) last released its quarterly earnings results on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.24 by $0.06. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The business had revenue of $6.38 billion during the quarter, compared to the consensus estimate of $6.60 billion. During the same period in the previous year, the company posted $2.20 EPS. The business’s quarterly revenue was down 1.2% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. On average, sell-side analysts anticipate that Corteva, Inc. will post 2.77 EPS for the current year.
Corteva Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st were issued a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a yield of 4.9%. The ex-dividend date of this dividend was Tuesday, September 1st. Corteva’s dividend payout ratio is currently 47.68%.
Corteva Company Profile
Corteva, Inc is an agriculture-focused company that develops and supplies seed, crop protection and digital agriculture products. Its offerings are designed to help farmers improve crop productivity, manage pests and diseases, and support more efficient and sustainable farming practices.
The company’s seed portfolio includes corn, soybean, wheat, sunflower, canola, cotton and other crops, marketed through brands such as Pioneer, Brevant seeds and PhytoGen. Corteva also provides herbicides, insecticides, fungicides, biological products and seed treatments under a range of agricultural brands.
Corteva serves farmers, agricultural retailers and other customers in markets around the world.
Further Reading
- Five stocks we like better than Corteva
- Skydance Just Became a Media Giant—With an $80 Billion Debt Load
- Could Velo3D Be the Next Defense Buyout Target?
- Penguin Solutions Is Soaring as AI Memory Demand Explodes
- Alphabet’s Chart Is Coiling—and the Fundamentals May Be Ready to Back It Up
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.
